A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of LY3375880 in Adult Subjects With Moderate-to-Severe Atopic Dermatitis: The ADmIRe Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of LY3375880 in Adult Subjects With Moderate-to-Severe Atopic Dermatitis: The ADmIRe Study
The reason for this study is to see if the study drug LY3375880 is safe and effective in adults with moderate-to-severe atopic dermatitis (AD).
Inclusion Criteria:
Exclusion Criteria:
CABA, Buenos Aires 1111, Argentina
Ciudad Autonoma Buenos Aires, C1055AA0, Argentina
Ciudad Autonoma Buenos Aires, C1425BEA, Argentina
Ciudad Autonoma Buenos Aires, C1425DKG, Argentina
Yufu-shi, Oita Prefecture 8795593, Japan
Nishi-ku Sakai-shi, Osaka 593-8324, Japan
Edogawa-ku, Tokyo 133-0057, Japan